GSI 150 (Zydelig 150 mg)

Generic Name: idelalisib

Pill imprint GSI 150 has been identified as Zydelig 150 mg.

Zydelig is used in the treatment of non-hodgkin's lymphoma; chronic lymphocytic leukemia; follicular lymphoma; lymphoma and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zydelig 150 mg is not a controlled substance under the Controlled Substance Act (CSA).

Zydelig

Generic Name:

idelalisib

Imprint:

GSI 150

Strength:

150 mg

Color:

Pink

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Multikinase inhibitors

Pregnancy Category:

D - Positive evidence of risk

CSA Schedule:

Not a controlled drug

Manufacturer:

Gilead Sciences, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.